Market Place
Sourcing Support
All News #Library
Biotech
Clover Names Nicholas Jackson President Of Global R&D & Alliances
20 Oct 2025 //
PR NEWSWIRE
Clover Announces U.S. IND Clearance for RSV Vaccine Study
23 Mar 2025 //
PR NEWSWIRE
Clover Shares Positive Data for RSV Vaccine Candidate SCB-1019
28 Oct 2024 //
PR NEWSWIRE
Clover Announces +ve Ph I Results for SCB-1019 in Initial Young Adult Cohort
08 Apr 2024 //
PR NEWSWIRE
Clover Initiates Phase 1 Clinical Trial for RSV Vaccine Candidate
12 Dec 2023 //
PR NEWSWIRE
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China
11 Sep 2023 //
GLOBENEWSWIRE
Clover Provides Updates on Business and R&D Pipeline Development
10 Jul 2023 //
GLOBENEWSWIRE
Clover Expands Sales and Distribution Network for Influenza Vaccine Launc
23 May 2023 //
GLOBENEWSWIRE
Clover Enters into Agreement for Quadrivalent Seasonal Influenza Vaccine
19 Feb 2023 //
GLOBENEWSWIRE
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
14 Feb 2023 //
GLOBENEWSWIRE
Clover Launches COVID-19 Booster Vaccine in the People’s Republic of China
13 Feb 2023 //
GLOBENEWSWIRE
Clover Provides Updates on COVID-19 Vaccine Commercial Launch in 2023
15 Jan 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.